JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 20 May 2002. doi:10.1083/jcb1575iti4
This Article
Right arrow Full Text (PDF, 191K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2002/5/734-a $5.00
The Journal of Cell Biology, Volume 157, Number 5, May 28, 2002 734-a-735


In This Issue

Blocking caspase-independent death


More neurons survive nonapoptotic death when given CsA (bottom).

Apoptotic cell death is executed by the caspase family of cysteine proteases. Apoptosis of injured neuronal cells can be inhibited by blocking caspases, but these cells still die eventually, via a second, nonapoptotic, mechanism that is not well understood. On page 771, Chang and Johnson demonstrate that this process can be prevented by blocking loss of mitochondrial membrane potential.

Using growth factor–deprived sympathetic neurons from rats, the authors found that cyclosporin A (CsA) provided protection to rat neurons from caspase- independent cell death. The drug probably acts by blocking the opening of the mitochondrial permeability transition pore (PTP), and thus preventing depolarization of the mitochondrial membrane. When caspases were active, CsA had no effect, suggesting that PTP opening is not critical during apoptosis.

Unlike rat neurons, mice sympathetic neurons were not protected by CsA. Neuron size may account for this difference, as smaller cells may be unable to survive until CsA arrives and mitochondria can reestablish their ion gradient. Johnson is optimistic that combinations of caspase inhibitors and CsA will have neuroprotective benefits in patients who have suffered a heart attack or stroke, although CsA may not be able to be given at a high enough does to completely block PTP. {blacksquare}



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 191K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents